SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-15-001524
Filing Date
2015-03-31
Accepted
2015-03-31 17:12:30
Documents
17
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT tnib_10k.htm 10-K 2100489
2 PROMISSORY NOTE SETTLEMENT AGREEMENT tnib_ex1020.htm EX-10.20 26600
3 PROMISSORY NOTE SETTLEMENT AGREEMENT tnib_ex1021.htm EX-10.21 25685
4 SERVICES AGREEMENT tnib_ex1028.htm EX-10.28 140222
5 CONSULTING AGREEMENT tnib_ex1029.htm EX-10.29 112525
6 LIST OF SUBSIDIARIES tnib_ex211.htm EX-21.1 3573
7 CERTIFICATE tnib_ex311.htm EX-31.1 16482
8 CERTIFICATE tnib_ex312.htm EX-31.2 14987
9 CERTIFICATE tnib_ex321.htm EX-32.1 7103
10 CERTIFICATE tnib_ex322.htm EX-32.2 7050
11 formula.jpg GRAPHIC 2631
  Complete submission text file 0001354488-15-001524.txt   5624814

Data Files

Seq Description Document Type Size
12 tnib-20141231.xml EX-101.INS 448650
13 tnib-20141231.xsd EX-101.SCH 48501
14 tnib-20141231_cal.xml EX-101.CAL 41694
15 tnib-20141231_def.xml EX-101.DEF 69847
16 tnib-20141231_lab.xml EX-101.LAB 275759
17 tnib-20141231_pre.xml EX-101.PRE 169199
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54933 | Film No.: 15740292
SIC: 2834 Pharmaceutical Preparations